1. Home
  2. AUPH vs PL Comparison

AUPH vs PL Comparison

Compare AUPH & PL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • PL
  • Stock Information
  • Founded
  • AUPH 1993
  • PL 2010
  • Country
  • AUPH Canada
  • PL United States
  • Employees
  • AUPH N/A
  • PL N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • PL Aerospace
  • Sector
  • AUPH Health Care
  • PL Industrials
  • Exchange
  • AUPH Nasdaq
  • PL Nasdaq
  • Market Cap
  • AUPH 1.4B
  • PL 2.2B
  • IPO Year
  • AUPH 1999
  • PL N/A
  • Fundamental
  • Price
  • AUPH $12.30
  • PL $10.25
  • Analyst Decision
  • AUPH Strong Buy
  • PL Buy
  • Analyst Count
  • AUPH 3
  • PL 14
  • Target Price
  • AUPH $12.00
  • PL $7.15
  • AVG Volume (30 Days)
  • AUPH 1.5M
  • PL 14.7M
  • Earning Date
  • AUPH 11-06-2025
  • PL 09-08-2025
  • Dividend Yield
  • AUPH N/A
  • PL N/A
  • EPS Growth
  • AUPH N/A
  • PL N/A
  • EPS
  • AUPH 0.42
  • PL N/A
  • Revenue
  • AUPH $260,111,000.00
  • PL $262,471,000.00
  • Revenue This Year
  • AUPH $16.92
  • PL $18.99
  • Revenue Next Year
  • AUPH $14.43
  • PL $19.30
  • P/E Ratio
  • AUPH $29.12
  • PL N/A
  • Revenue Growth
  • AUPH 25.59
  • PL 11.33
  • 52 Week Low
  • AUPH $6.55
  • PL $2.02
  • 52 Week High
  • AUPH $12.90
  • PL $10.40
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 56.77
  • PL 75.45
  • Support Level
  • AUPH $12.06
  • PL $6.26
  • Resistance Level
  • AUPH $12.90
  • PL $10.11
  • Average True Range (ATR)
  • AUPH 0.39
  • PL 0.67
  • MACD
  • AUPH -0.08
  • PL 0.27
  • Stochastic Oscillator
  • AUPH 54.89
  • PL 96.26

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

Share on Social Networks: